GPER Deletion Triggers Inhibitory Effects in Triple Negative Breast Cancer (TNBC) Cells through the JNK/c-Jun/p53/Noxa Transduction Pathway

Scientists aimed at providing new mechanistic and biological discoveries knocking out G protein-coupled estrogen receptor (GPER) expression by CRISPR/Cas9 technology in MDA-MB-231 TNBC cells.